Status:
UNKNOWN
a Prospective Pilot Study of Screening Out Rate and Clinical Management of Familial Hypercholesterolemia
Lead Sponsor:
China Cardiovascular Association
Collaborating Sponsors:
Amgen
Conditions:
Familial Hypercholesterolemia
Eligibility:
All Genders
Brief Summary
1. Primary Objective To estimate the prevalence of clinical diagnosed familial hypercholesterolemia, as well as the clinical characteristics and current treatment, with applying China recent issued FH...
Detailed Description
1. Objective 1.1.Primary Objective To estimate the prevalence of clinical diagnosed familial hypercholesterolemia, as well as the clinical characteristics and current treatment, with applying China re...
Eligibility Criteria
Inclusion
- Written inform consent provided.
- Male and female cardiovascular outpatients and inpatients with LDL-C\>4.65mmol/L if statin naïve or LDL-C\>3.7mmol/L if on statin treatment before enrollment during Sept.2017 to Sept. 2019.
Exclusion
- Subjects who cannot understand study procedure
- Subjects diagnosed as secondary dyslipidemia
Key Trial Info
Start Date :
January 18 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2019
Estimated Enrollment :
1128 Patients enrolled
Trial Details
Trial ID
NCT03398954
Start Date
January 18 2018
End Date
December 30 2019
Last Update
March 12 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Anzhen Hospital
Beijing, Beijing Municipality, China